Jeffrey E. DeClue

3.4k total citations
43 papers, 2.9k citations indexed

About

Jeffrey E. DeClue is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Jeffrey E. DeClue has authored 43 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Physiology and 13 papers in Neurology. Recurrent topics in Jeffrey E. DeClue's work include Tuberous Sclerosis Complex Research (16 papers), Neurofibromatosis and Schwannoma Cases (12 papers) and Protein Kinase Regulation and GTPase Signaling (9 papers). Jeffrey E. DeClue is often cited by papers focused on Tuberous Sclerosis Complex Research (16 papers), Neurofibromatosis and Schwannoma Cases (12 papers) and Protein Kinase Regulation and GTPase Signaling (9 papers). Jeffrey E. DeClue collaborates with scholars based in United States, Germany and Canada. Jeffrey E. DeClue's co-authors include Douglas R. Lowy, Ralf Wienecke, Greg S. Martin, William C. Vass, Adrian König, Alex G. Papageorge, Bruce D. Cohen, Nancy Ratner, Thomas D. Gilmore and John C. Maize and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jeffrey E. DeClue

43 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey E. DeClue United States 29 1.6k 878 687 528 428 43 2.9k
Håkan Axelson Sweden 37 2.8k 1.8× 178 0.2× 554 0.8× 885 1.7× 315 0.7× 90 4.1k
Roberta L. Beauchamp United States 24 657 0.4× 231 0.3× 465 0.7× 575 1.1× 223 0.5× 41 1.8k
Janet C. Lindsey United Kingdom 23 1.6k 1.0× 394 0.4× 294 0.4× 191 0.4× 115 0.3× 41 2.4k
Sandra L. Dabora United States 18 1.2k 0.8× 1.6k 1.8× 80 0.1× 695 1.3× 388 0.9× 28 2.7k
Leah Conroy United States 12 1.5k 0.9× 118 0.1× 680 1.0× 291 0.6× 521 1.2× 13 2.3k
Rui Benedito Spain 25 3.3k 2.1× 201 0.2× 262 0.4× 622 1.2× 873 2.0× 36 4.5k
Andrew S. Venteicher United States 16 2.4k 1.6× 1.3k 1.5× 179 0.3× 386 0.7× 119 0.3× 53 3.5k
Collins Vp Sweden 24 1.3k 0.8× 91 0.1× 398 0.6× 492 0.9× 361 0.8× 65 2.4k
Rónán C. O’Hagan United States 18 2.2k 1.4× 410 0.5× 116 0.2× 1.1k 2.1× 323 0.8× 30 3.1k
Josiane Grosgeorge France 19 2.0k 1.3× 134 0.2× 141 0.2× 658 1.2× 160 0.4× 32 3.1k

Countries citing papers authored by Jeffrey E. DeClue

Since Specialization
Citations

This map shows the geographic impact of Jeffrey E. DeClue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. DeClue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. DeClue more than expected).

Fields of papers citing papers by Jeffrey E. DeClue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey E. DeClue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. DeClue. The network helps show where Jeffrey E. DeClue may publish in the future.

Co-authorship network of co-authors of Jeffrey E. DeClue

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey E. DeClue. A scholar is included among the top collaborators of Jeffrey E. DeClue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey E. DeClue. Jeffrey E. DeClue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lowy, Douglas R., Jeffrey E. DeClue, Ke Zhang, et al.. (2007). Cell Transformation by ras and Regulation of its Protein Product. Novartis Foundation symposium. 176. 67–84. 1 indexed citations
2.
Ling, Benjamin, Jianqiang Wu, Shyra J. Miller, et al.. (2005). Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell. 7(1). 65–75. 99 indexed citations
3.
Ess, Kevin C., Erik J. Uhlmann, Wen Li, et al.. (2004). Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology. Glia. 46(1). 28–40. 28 indexed citations
4.
DeClue, Jeffrey E., Heinz Kutzner, Arno Rütten, et al.. (2003). Loss of expression of tuberin and hamartin in tuberous sclerosis complex‐associated but not in sporadic angiofibromas. Journal of Cutaneous Pathology. 30(3). 174–177. 8 indexed citations
5.
Li, Shaowei, Richard Braverman, Hongzhen Li, et al.. (2003). Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E‐cadherin/β‐catenin activity. Molecular Carcinogenesis. 37(2). 98–109. 9 indexed citations
6.
7.
DeClue, Jeffrey E., Christian A. Sander, Matthias Volkenandt, et al.. (2001). Loss of tuberin, the tuberous‐sclerosis‐complex‐2 gene product is associated with angiogenesis. Journal of Cutaneous Pathology. 28(9). 470–475. 32 indexed citations
8.
Benvenuto, Giovanna, Shaowei Li, Richard Braverman, et al.. (2000). The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene. 19(54). 6306–6316. 203 indexed citations
9.
Kleymenova, Elena, Jeffrey E. DeClue, & Cheryl L. Walker. (1999). Genetic variants of the tuberous sclerosis 2 tumour suppressor gene in mouse t haplotypes. Genetics Research. 74(2). 139–144. 2 indexed citations
10.
Vinters, Harry V., et al.. (1998). Tuberous sclerosis-related gene expression in normal and dysplastic brain. Epilepsy Research. 32(1-2). 12–23. 29 indexed citations
11.
Lee, Michael, Wayne B. Anderson, Giovanna Benvenuto, et al.. (1997). Sequential Modification of Serines 621 and 624 in the Raf-1 Carboxyl Terminus Produces Alterations in Its Electrophoretic Mobility. Journal of Biological Chemistry. 272(4). 2136–2142. 23 indexed citations
12.
Park, Sung‐Hye, Samuel H. Pepkowitz, Christopher A. Kerfoot, et al.. (1997). Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathologica. 94(2). 180–186. 79 indexed citations
13.
Gutmann, David H., Susan M. Saporito-Irwin, Jeffrey E. DeClue, Ralf Wienecke, & Abhijit Guha. (1997). Alterations in the rap1 signaling pathway are common in human gliomas. Oncogene. 15(13). 1611–1616. 40 indexed citations
14.
Wienecke, Ralf, Abhijit Guha, John C. Maize, et al.. (1997). Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Annals of Neurology. 42(2). 230–235. 36 indexed citations
15.
Kerfoot, Christopher A., Ralf Wienecke, Michael Menchine, et al.. (1996). Localization of Tuberous Sclerosis 2 mRNA and its Protein Product Tuberin in Normal Human Brain and in Cerebral Lesions of Patients with Tuberous Sclerosis. Brain Pathology. 6(4). 367–375. 51 indexed citations
16.
Wienecke, Ralf, Adrian König, & Jeffrey E. DeClue. (1995). Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY. Journal of Biological Chemistry. 270(27). 16409–16414. 299 indexed citations
17.
DeClue, Jeffrey E., et al.. (1994). Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Molecular and Cellular Biology. 14(1). 641–645. 7 indexed citations
18.
DeClue, Jeffrey E., et al.. (1991). Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus.. Molecular and Cellular Biology. 11(5). 2819–2825. 92 indexed citations
19.
Zhang, Ke, Jeffrey E. DeClue, William C. Vass, et al.. (1990). Suppression of c-ras transformation by GTPase-activating protein. Nature. 346(6286). 754–756. 141 indexed citations
20.
DeClue, Jeffrey E. & Greg S. Martin. (1987). Phosphorylation of Talin at Tyrosine in Rous Sarcoma Virus-Transformed Cells. Molecular and Cellular Biology. 7(1). 371–378. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Håkan Axelson Breakdown of academic impact, for papers by Roberta L. Beauchamp Breakdown of academic impact, for papers by Janet C. Lindsey Breakdown of academic impact, for papers by Sandra L. Dabora Breakdown of academic impact, for papers by Leah Conroy Breakdown of academic impact, for papers by Rui Benedito Breakdown of academic impact, for papers by Andrew S. Venteicher Breakdown of academic impact, for papers by Collins Vp Breakdown of academic impact, for papers by Rónán C. O’Hagan Breakdown of academic impact, for papers by Josiane Grosgeorge
Rankless by CCL
2026